Variant report
Variant | nsv6478 |
---|---|
Chromosome Location | chr9:10382390-10426916 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs573793275 | chr9:10384820-10384821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs1407921 | chr9:10384822-10384823 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs374221893 | chr9:10384827-10384828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559617102 | chr9:10384839-10384840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs138443209 | chr9:10384888-10384889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550337176 | chr9:10384927-10384928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551374874 | chr9:10385052-10385053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs377713734 | chr9:10385053-10385054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7873950 | chr9:10385072-10385073 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs531122474 | chr9:10385121-10385122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs114737249 | chr9:10385142-10385143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs567846727 | chr9:10385147-10385148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536476748 | chr9:10385167-10385168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs117384205 | chr9:10385170-10385171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs371373604 | chr9:10385178-10385179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10959086 | chr9:10385183-10385184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1323483 | chr9:10385200-10385201 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs557791485 | chr9:10385214-10385215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534290408 | chr9:10385244-10385245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs571589757 | chr9:10385258-10385259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577969321 | chr9:10385325-10385326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557336166 | chr9:10385356-10385357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs143992295 | chr9:10385360-10385361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs62540993 | chr9:10385388-10385389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs374201734 | chr9:10385445-10385446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557019229 | chr9:10385455-10385456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573755908 | chr9:10385463-10385464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs542488978 | chr9:10385468-10385469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181699711 | chr9:10385483-10385484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573019713 | chr9:10385504-10385505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs543392881 | chr9:10385515-10385516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs544963627 | chr9:10385544-10385545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs557117111 | chr9:10385546-10385547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs73404238 | chr9:10385573-10385574 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs111236856 | chr9:10385587-10385588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs573785004 | chr9:10385599-10385600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs186839708 | chr9:10385600-10385601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148642774 | chr9:10385605-10385606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190841973 | chr9:10385634-10385635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565733259 | chr9:10385657-10385658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs534716903 | chr9:10385686-10385687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs183391958 | chr9:10385702-10385703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs375595585 | chr9:10385709-10385710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs186647993 | chr9:10385761-10385762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs557203201 | chr9:10385772-10385773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs10738163 | chr9:10385811-10385812 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs562008139 | chr9:10385817-10385818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs536415277 | chr9:10385825-10385826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs71485331 | chr9:10385842-10385843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs71332739 | chr9:10385848-10385849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Attention deficit hyperactivity disorder | 19546859 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Glioma | 20126413 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:10384800-10385200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr9:10385000-10385200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr9:10385200-10387200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
4 | chr9:10387200-10387600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr9:10387200-10387600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr9:10387200-10387800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr9:10387200-10387800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr9:10387400-10387800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr9:10387800-10395800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr9:10395800-10396000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
11 | chr9:10395800-10396200 | Active TSS | Breast Myoepithelial Primary Cells | Breast |
12 | chr9:10396000-10397200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr9:10396600-10397000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
14 | chr9:10397200-10397400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr9:10397200-10398000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
16 | chr9:10398800-10399200 | Enhancers | Fetal Heart | heart |